Find your next paid study

City of Hope Medical CenterNCT05225363

~$150 – $3,000

Actual pay is set by the research site.

Opioid-use DisorderSubstance Use Disorders

A Feasibility Clinical Trial of Exablate for Low Intensity Focused Ultrasound Neuromodulation in Patients With Opioid Use Disorder (OUD) and/or Other Substance Abuse Disorders (SUDs)

The purpose of this clinical trial is to investigate Low Intensity Focused Ultrasound (LIFU) using the Exablate® Model 4000 Type 2.0/2.1 as an adjunctive neuro…

~$10 – $1,125

Actual pay is set by the research site.

InSightecNCT04197921

Elevated Blood PressureHypertension

A Pivotal Study to Evaluate the Effectiveness of Isometric Handgrip Therapy in Elevated Blood Pressure and Hypertensive Subjects

The study will be a multi-center, randomized clinical trial to evaluate the safety and efficacy of using the Zona Plus handgrip therapy device compared to the …

Zona Health, IncNCT06843577

~$10 – $1,050

Actual pay is set by the research site.

Phase 1/2A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients With Advanced Solid Tumors

The main goals of this clinical trial are to find out what the best dose of the study drug, OTP-01, is for patients with solid tumors through understanding how…

Advanced Solid Tumors

Ottimo Pharma LimitedNCT07266428

~$150 – $4,200

Actual pay is set by the research site.

Neoplasm - Soft Tissue Pelvis Malignant SecondaryMalignant Neoplasm of Stomach

Adaptive Radiation for Abdominopelvic Metastases (ARAM)

Single arm Phase I trial of adaptive stereotactic body radiation (SBRT) for abdominopelvic metastases. Adaptive SBRT will allow for escalation of the prescript…

Fox Chase Cancer CenterNCT05880667

~$150 – $3,000

Actual pay is set by the research site.

Phase 3

A Phase 3, Randomized, Open-label Study to Evaluate the Efficacy and Safety of Sac-TMT (Sacituzumab Tirumotecan, MK-2870) Followed by Carboplatin/Paclitaxel vs Chemotherapy, Both in Combination With Pembrolizumab as Neoadjuvant Therapy for High-Risk, Early-Stage, Triple-Negative Breast Cancer or Hormone Receptor-low Positive/Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer

Researchers are looking for new ways to treat types of breast cancer that are both: * High-risk, which means the cancer may have a higher chance of getting wo…

Breast NeoplasmsTriple Negative Breast NeoplasmsHR Low-Positive/HER2-Negative Breast Neoplasms

Merck Sharp & Dohme LLCNCT06966700

~$50 – $2,100

Actual pay is set by the research site.

PhysicianSurgeonResident Doctor+3 more

Deformable Tissue Modelling and Augmented Reality Based Guidance for Head and Neck Tumor Re-Resection Task

Head and neck cancers have one of the highest recurrence rates among solid malignancies, and recurrence is strongly correlated with overall survival. Reducing …

Vanderbilt University Medical CenterNCT07686211

~$150 – $3,000

Actual pay is set by the research site.

CoughVocal Cord AtrophyVocal Cord Paresis+3 more

Usefulness and Feasibility of Ultrasound in Office Laryngology Procedures: A Pilot Study

Investigators will assess the usefulness of using ultrasound in office procedures for laryngology interventions. Participants who qualify will be adults who ar…

Weill Medical College of Cornell UniversityNCT06579989

Actual pay is set by the research site.

A Study to Evaluate the Safety and Efficacy of Intracranial Venous Blood Sampling for Liquid Biopsy in the Diagnosis of Brain Cancers

To learn if drawing blood directly from veins inside the brain is safe and can effectively provide the same kind of detailed information about high-grade gliom…

Intracranial Venous BloodBrain CancersLiquid Biopsy+1 more

M.D. Anderson Cancer CenterNCT07467109

Actual pay is set by the research site.

Integrated Glofit and Ibrutinib as Novel Immune Therapy Evaluation in Treatment-Naive Mantle Cell Lymphoma (IGNITE MCL): A Phase Ib/II Study of Glofitamab Plus Ibrutinib With Obinutuzumab Pretreatment in MCL Patients ≥ 65 or Ages 18-64 With High-Risk Features

This phase IB/II trial tests the safety, side effects and effectiveness of glofitamab plus ibrutinib with obinutuzumab for the treatment of patients with mantl…

Mantle Cell Lymphoma

OHSU Knight Cancer InstituteNCT06357676

~$150 – $4,500

Actual pay is set by the research site.

CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study

The purpose of this study is to identify multiple myeloma in the precancerous MGUS stage in order to reduce the risk of delayed diagnosis of multiple myeloma, …

Multiple MyelomaMultiple Myeloma ProgressionMonoclonal Gammopathy of Undetermined Significance (MGUS)+2 more

Wake Forest University Health SciencesNCT06644625

Actual pay is set by the research site.

Understanding the Neurophysiology of Ankle Instability to Improve Rehabilitation Outcomes

Chronic ankle instability (CAI) is a common debilitating orthopedic condition that disrupts physical function and decreases quality of life. Not all CAI is the…

Ankle Injuries